BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9393881)

  • 1. Deletional remodeling of c-myc-deregulating chromosomal translocations.
    Kovalchuk AL; Müller JR; Janz S
    Oncogene; 1997 Nov; 15(19):2369-77. PubMed ID: 9393881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic recombinations between c-myc and Igh mu as precursors for recombinations between c-myc and Igh alpha in BALB/c plasmacytomas.
    Janz S; Kovalchuk AL; Müller JR; Potter M
    Curr Top Microbiol Immunol; 1997; 224():241-50. PubMed ID: 9308247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E mu/S mu transposition into Myc is sometimes a precursor for T(12;15) translocation in mouse B cells.
    Kovalchuk AL; Kim JS; Janz S
    Oncogene; 2003 May; 22(18):2842-50. PubMed ID: 12743607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences between Burkitt's lymphomas and mouse plasmacytomas in the immunoglobulin heavy chain/c-myc recombinations that occur in their chromosomal translocations.
    Müller JR; Janz S; Potter M
    Cancer Res; 1995 Nov; 55(21):5012-8. PubMed ID: 7585544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin/Myc recombinations in murine Peyer's patch follicles.
    Müller JR; Mushinski EB; Williams JA; Hausner PF
    Genes Chromosomes Cancer; 1997 Sep; 20(1):1-8. PubMed ID: 9290947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Location of Myc, Igh, and Igk on Robertsonian fusion chromosomes is inconsequential for Myc translocations and plasmacytoma development in mice, but Rb(6.15)-carrying tumors prefer Igk-Myc inversions over translocations.
    Silva S; Wiener F; Klein G; Janz S
    Genes Chromosomes Cancer; 2005 Apr; 42(4):416-26. PubMed ID: 15645495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-myc-S mu rearrangement in a murine plasmacytoma without visible chromosomal translocations.
    Ohno S; Migita S; Murakami S
    Oncogene; 1989 Dec; 4(12):1513-7. PubMed ID: 2687771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel c-myc-activating reciprocal T(12;15) chromosomal translocation juxtaposes S alpha to Pvt-1 in a mouse plasmacytoma.
    Shaughnessy J; Wiener F; Huppi K; Mushinski JF; Potter M
    Oncogene; 1994 Jan; 9(1):247-53. PubMed ID: 8302586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myc translocations in B cell and plasma cell neoplasms.
    Janz S
    DNA Repair (Amst); 2006 Sep; 5(9-10):1213-24. PubMed ID: 16815105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AID and Igh switch region-Myc chromosomal translocations.
    Unniraman S; Schatz DG
    DNA Repair (Amst); 2006 Sep; 5(9-10):1259-64. PubMed ID: 16784901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal translocations deregulating c-myc are associated with normal immune responses.
    Roschke V; Kopantzev E; Dertzbaugh M; Rudikoff S
    Oncogene; 1997 Jun; 14(25):3011-6. PubMed ID: 9223664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic characterization of the chromosomal breakpoints of t(4;14) of multiple myeloma suggests more than one possible aetiological mechanism.
    Fenton JA; Pratt G; Rawstron AC; Sibley K; Rothwell D; Yates Z; Dring A; Richards SJ; Ashcroft AJ; Davies FE; Owen RG; Child JA; Morgan GJ
    Oncogene; 2003 Feb; 22(7):1103-13. PubMed ID: 12592397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two antisense promoters in the immunoglobulin mu-switch region drive expression of c-myc in the Burkitt's lymphoma cell line BL67.
    Apel TW; Mautner J; Polack A; Bornkamm GW; Eick D
    Oncogene; 1992 Jul; 7(7):1267-71. PubMed ID: 1620543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of an AID-independent pathway for chromosomal translocations between the Igh switch region and Myc.
    Unniraman S; Zhou S; Schatz DG
    Nat Immunol; 2004 Nov; 5(11):1117-23. PubMed ID: 15489857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extraosseous IL-6 transgenic mouse plasmacytoma sometimes lacks Myc-activating chromosomal translocation.
    McNeil N; Kim JS; Ried T; Janz S
    Genes Chromosomes Cancer; 2005 Jun; 43(2):137-46. PubMed ID: 15751044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insertion of Myc into Igh accelerates peritoneal plasmacytomas in mice.
    Park SS; Shaffer AL; Kim JS; duBois W; Potter M; Staudt LM; Janz S
    Cancer Res; 2005 Sep; 65(17):7644-52. PubMed ID: 16140930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal diversification of primary BALB/c plasmacytomas harboring T(12;15) chromosomal translocations.
    Kovalchuk AL; Mushinski EB; Janz S
    Leukemia; 2000 May; 14(5):909-21. PubMed ID: 10803525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic instability in B-cells and diversity of recombinations that activate c-myc.
    Janz S; Jones GM; Müller JR; Potter M
    Curr Top Microbiol Immunol; 1995; 194():373-80. PubMed ID: 7895512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of immunoglobulin/c-myc recombinations in mice that are resistant to plasmacytoma induction.
    Müller JR; Jones GM; Potter M; Janz S
    Cancer Res; 1996 Jan; 56(2):419-23. PubMed ID: 8542601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
    Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
    Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.